Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/1/2001
 
First Published:
7/1/2000
1.
Phase I/II Study of Daunorubicin Liposomal and SU5416 in Patients With Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts (RAEB), RAEB in Transformation, or Chronic Myelomonocytic Leukemia Refractory to Induction Chemotherapy (Summary Last Modified 05/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 and over
NCI
MDA-ID-99341
NCI-673, NCT00005942, 673
Last Modified:
6/12/2007
 
First Published:
7/1/2000
2.
Phase II Randomized Study of Gemtuzumab Ozogamicin and Cytarabine Versus Daunorubicin Liposomal and Cytarabine Versus Cyclophosphamide, Cytarabine, and Topotecan in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
E-4999
NCT00005962, E4999
Last Modified:
7/1/2000
 
First Published:
1/1/2000
3.
Phase I Study of Daunorubicin Liposomal in Patients With Metastatic Breast Cancer (Summary Last Modified 07/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
Other
LRI-103-UK-V1.1
EU-99033, NCT00004207
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute